AbSci, a global leader in breakthrough biomanufacturing technologies, announced that it closed its Series B financing round for an undisclosed amount. The round includes previous investors along with several new investors …
- AbSci hopes to make E. Coli great again through engineered expression system
- AbSci Adds Protein Characterization Expert, Alan Herman, PhD to Scientific Advisory Board
- AbSci Appoints William F. Bennett, PhD to Scientific Advisory Board
- AbSci at 36th JP Morgan Conference January 8th – 11th.
- AbSci Appoints Fred Larimore, PhD to Scientific Advisory Board